330 related articles for article (PubMed ID: 10333980)
1. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
Horst WD; Preskorn SH
J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
Augustin BG; Cold JA; Jann MW
Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
[TBL] [Abstract][Full Text] [Related]
3. New antidepressant drugs and the treatment of depression in the medically ill patient.
Stoudemire A
Psychiatr Clin North Am; 1996 Sep; 19(3):495-514. PubMed ID: 8856814
[TBL] [Abstract][Full Text] [Related]
4. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Masand PS; Gupta S
Ann Clin Psychiatry; 2002 Sep; 14(3):175-82. PubMed ID: 12585567
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological justification for the use of new antidepressant drugs].
Nowakowska E; Kus K; Bobkiewicz-Kozłowska T
Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Preskorn SH
J Clin Psychiatry; 1995; 56 Suppl 6():12-21. PubMed ID: 7649968
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of the new antidepressants.
Nelson JC
J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
[TBL] [Abstract][Full Text] [Related]
8. Nefazodone and venlafaxine: two new agents for the treatment of depression.
Goldberg RJ
J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
[TBL] [Abstract][Full Text] [Related]
10. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
Owen JR; Nemeroff CB
Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
[TBL] [Abstract][Full Text] [Related]
11. Three new antidepressants.
Drug Ther Bull; 1996 Sep; 34(9):65-8. PubMed ID: 8885497
[No Abstract] [Full Text] [Related]
12. Therapeutic drug monitoring of non-tricyclic antidepressant drugs.
Mitchell PB
Clin Chem Lab Med; 2004; 42(11):1212-8. PubMed ID: 15576285
[TBL] [Abstract][Full Text] [Related]
13. [Applications and safety of modern antidepressants in patients with liver diseases].
Dubarek W; Kucia K
Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
[TBL] [Abstract][Full Text] [Related]
14. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
Stahl SM
J Clin Psychiatry; 1998; 59 Suppl 4():5-14. PubMed ID: 9554316
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants.
Frazer A
J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
[No Abstract] [Full Text] [Related]
16. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
Möller HJ; Volz HP
Drugs; 1996 Nov; 52(5):625-38. PubMed ID: 9118813
[TBL] [Abstract][Full Text] [Related]
17. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
Kent JM
Lancet; 2000 Mar; 355(9207):911-8. PubMed ID: 10752718
[TBL] [Abstract][Full Text] [Related]
18. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Sussman N; Ginsberg DL; Bikoff J
J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
Fatemi SH; Emamian ES; Kist DA
Ann Pharmacother; 1999 Jun; 33(6):701-3. PubMed ID: 10410184
[TBL] [Abstract][Full Text] [Related]
20. [Review of antidepressants from the TCAs to the third generation drugs].
Almási J; Rihmer Z
Neuropsychopharmacol Hung; 2004 Dec; 6(4):185-94. PubMed ID: 15825674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
